Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03999411Phase 4Completed
Phase 4, randomised, open-label trial (3 arms), sponsored by University of Miami. Primary endpoints: Number of Participants With Smoking Cessation at 3 months, Number of Participants With >= 95% Adherence to ART Medication at 3 months and 4 more. Started Sep 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03999411.